Your browser doesn't support javascript.
loading
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.
Bonilla, Weldy V; Kirchhammer, Nicole; Marx, Anna-Friederike; Kallert, Sandra M; Krzyzaniak, Magdalena A; Lu, Min; Darbre, Stéphanie; Schmidt, Sarah; Raguz, Josipa; Berka, Ursula; Vincenti, Ilena; Pauzuolis, Mindaugas; Kerber, Romy; Hoepner, Sabine; Günther, Stephan; Magnus, Carsten; Merkler, Doron; Orlinger, Klaus K; Zippelius, Alfred; Pinschewer, Daniel D.
Afiliação
  • Bonilla WV; University of Basel, Department of Biomedicine, Basel, Switzerland.
  • Kirchhammer N; University of Basel, Department of Biomedicine, Basel, Switzerland.
  • Marx AF; University of Basel, Department of Biomedicine, Basel, Switzerland.
  • Kallert SM; University of Basel, Department of Biomedicine, Basel, Switzerland.
  • Krzyzaniak MA; University of Basel, Department of Biomedicine, Basel, Switzerland.
  • Lu M; University of Basel, Department of Biomedicine, Basel, Switzerland.
  • Darbre S; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Schmidt S; Hookipa Pharma Inc., Vienna, Austria.
  • Raguz J; Hookipa Pharma Inc., Vienna, Austria.
  • Berka U; Hookipa Pharma Inc., Vienna, Austria.
  • Vincenti I; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Pauzuolis M; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Kerber R; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Hoepner S; Tumor Immunology, Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Magnus C; Institute of Virology, University of Zurich, Zurich, Switzerland.
  • Merkler D; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
  • Orlinger KK; Division of Clinical Pathology, University Hospitals of Geneva, Geneva, Switzerland.
  • Zippelius A; Hookipa Pharma Inc., Vienna, Austria.
  • Pinschewer DD; University of Basel, Department of Biomedicine, Basel, Switzerland.
Cell Rep Med ; 2(3): 100209, 2021 03 16.
Article em En | MEDLINE | ID: mdl-33763654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Vírus Pichinde / Vacinas Anticâncer / Mastocitoma / Imunoterapia / Vírus da Coriomeningite Linfocítica Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Vírus Pichinde / Vacinas Anticâncer / Mastocitoma / Imunoterapia / Vírus da Coriomeningite Linfocítica Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article